Published in Crit Care on April 02, 2008
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med (2008) 1.30
Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases. J Cell Death (2010) 0.97
Year in review 2008: Critical Care--sepsis. Crit Care (2009) 0.86
A dual-role of Gu-4 in suppressing HMGB1 secretion and blocking HMGB1 pro-inflammatory activity during inflammation. PLoS One (2014) 0.78
Enoxaparin sodium prevents intestinal microcirculatory dysfunction in endotoxemic rats. Crit Care (2012) 0.77
Progranulin deficiency leads to severe inflammation, lung injury and cell death in a mouse model of endotoxic shock. J Cell Mol Med (2016) 0.76
Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases. J Cell Death (2010) 0.75
Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses. Gene Regul Syst Bio (2017) 0.75
The acute respiratory distress syndrome. N Engl J Med (2000) 25.38
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
IL-10 inhibits cytokine production by activated macrophages. J Immunol (1991) 13.13
Macrophage deactivation by interleukin 10. J Exp Med (1991) 6.94
High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol (2005) 5.04
Proteinase-activated receptors. Pharmacol Rev (2001) 5.02
Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol (1999) 4.91
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood (2002) 3.70
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol (2004) 3.65
Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med (2007) 3.27
IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J (1998) 2.99
RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol (2005) 2.96
Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem (1999) 2.79
Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med (2004) 2.50
Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia--a review. Crit Care Med (2006) 2.45
A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis. Shock (2003) 1.61
The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med (1996) 1.56
Role of coagulation inhibitors in inflammation. Thromb Haemost (2001) 1.40
HMG-1 rediscovered as a cytokine. Shock (2001) 1.37
Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood (2001) 1.37
Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med (2001) 1.33
Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock (2002) 1.30
Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol (2002) 1.23
Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci (1996) 1.19
Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch Chest Dis (1997) 1.08
Endotoxin-induced organ injury. Crit Care Med (1993) 1.06
Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation. J Pharmacol Exp Ther (2005) 0.90
Effects of anticoagulant strategies on activation of inflammation and coagulation. Expert Opin Biol Ther (2007) 0.89
The role of the endothelium in changes in procoagulant activity in sepsis. J Am Coll Surg (1998) 0.88
Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis (1992) 0.87
Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin. Intensive Care Med (2005) 0.83
A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock. J Pharmacol Exp Ther (2002) 0.83
Factor Xa-inhibitor (DX-9065a) modulates the leukocyte-endothelial cell interaction in endotoxemic rat. Shock (2002) 0.82
Danaparoid in the prevention of thromboembolic complications. Ann Pharmacother (1997) 0.77
Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm (2012) 1.77
Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med (2009) 1.71
Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med (2008) 1.69
High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med (2007) 1.63
Hyperglycemia contributes to cardiac dysfunction in a lipopolysaccharide-induced systemic inflammation model. Crit Care Med (2009) 1.44
New lipoic acid derivative drug sodium zinc dihydrolipoylhistidinate prevents cardiac dysfunction in an isolated perfused rat heart model. Crit Care Med (2011) 1.44
Anesthetic management of a patient with hyperthyroidism due to hydatidiform mole. J Anesth (2009) 1.15
Mechanisms of analgesic action of pulsed radiofrequency on adjuvant-induced pain in the rat: roles of descending adrenergic and serotonergic systems. Eur J Pain (2008) 1.09
Retracted Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood (2002) 1.08
Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats. Intensive Care Med (2009) 1.02
Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock (2009) 1.01
Pulmonary changes in a mouse model of combined burn and smoke inhalation-induced injury. J Appl Physiol (1985) (2008) 0.99
Effect of Ulinastatin, a human urinary trypsin inhibitor, on the oleic acid-induced acute lung injury in rats via the inhibition of activated leukocytes. Injury (2005) 0.98
Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury. J Anesth (2010) 0.97
Virus associated hemophagocytic syndrome accompanied by acute respiratory failure caused by influenza A (H3N2). Intern Med (2006) 0.97
C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. Cardiovasc Pathol (2007) 0.96
GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med (2007) 0.95
A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1. Inflammation (2008) 0.93
The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. J Clin Anesth (2007) 0.93
Pre-Irradiation of blood by gallium aluminum arsenide (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Anesth Analg (2008) 0.92
Use of imaging agent to determine postoperative indwelling epidural catheter position. Korean J Pain (2010) 0.89
Decrease in expression of alpha 5 beta 1 integrin during neuronal differentiation of cortical progenitor cells. Exp Cell Res (2003) 0.89
High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med (2008) 0.89
Antiproliferative effects of a new α-lipoic acid derivative, DHL-HisZnNa, in HT29 human colon cancer cells in vitro. Expert Opin Ther Targets (2012) 0.89
ETS-GS, a new antioxidant, ameliorates renal ischemia-reperfusion injury in a rodent model. J Surg Res (2010) 0.89
[Th1/Th2 balance in systemic inflammatory response syndrome (SIRS)]. Nihon Rinsho (2004) 0.87
In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models. Shock (2010) 0.87
Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model. Shock (2011) 0.86
High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock: a pilot study. Circ J (2008) 0.86
Antisense oligonucleotide inhibition of heat shock protein (HSP) 47 improves bleomycin-induced pulmonary fibrosis in rats. Respir Res (2007) 0.85
Age-dependent responses to renal ischemia-reperfusion injury. J Surg Res (2010) 0.85
An antisense oligonucleotide to HSP47 inhibits paraquat-induced pulmonary fibrosis in rats. Toxicology (2007) 0.85
Antithrombin III prevents cerulein-induced acute pancreatitis in rats. Pancreas (2009) 0.84
Stimulation of autophagy in the liver by lipopolysaccharide-induced systemic inflammation in a rat model of diabetes mellitus. Biomed Res (2010) 0.84
Retracted Coexpression of HSP47 gene and type I and type III collagen genes in LPS-induced pulmonary fibrosis in rats. Lung (2007) 0.84
Heat shock protein 72 protects insulin-secreting beta cells from lipopolysaccharide-induced endoplasmic reticulum stress. Int J Hyperthermia (2009) 0.83
Change in free radical-related substances in plasma following ischemia-reperfusion in rat liver. Pathophysiology (2002) 0.83
Infusion of a glucose solution reduces autophagy in the liver after LPS-induced systemic inflammation. Inflammation (2012) 0.83
Recombinant thrombomodulin prevents heatstroke by inhibition of high-mobility group box 1 protein in sera of rats. Shock (2010) 0.83
Conversion of atrial flutter to sinus rhythm during landiolol infusion. J Anesth (2009) 0.83
Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7. Shock (2007) 0.82
Filtration leukocytapheresis therapy ameliorates lipopolysaccharide-induced systemic inflammation in a rat model. J Surg Res (2010) 0.82
Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF). Yakugaku Zasshi (2010) 0.82
Transplantation of GABAergic neurons into adult mouse neocortex. Exp Neurol (2005) 0.82
Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. J Surg Res (2009) 0.82
Alternate day calorie restriction improves systemic inflammation in a mouse model of sepsis induced by cecal ligation and puncture. J Surg Res (2010) 0.81
A newly synthetic vitamin E derivative, E-Ant-S-GS, attenuates lung injury caused by cecal ligation and puncture-induced sepsis in rats. Surgery (2011) 0.81
High-dose antithrombin III prevents heat stroke by attenuating systemic inflammation in rats. Inflamm Res (2010) 0.81
The vitamin E derivative, EPC-K1, suppresses inflammation during hepatic ischemia-reperfusion injury and exerts hepatoprotective effects in rats. J Surg Res (2011) 0.81
Dihydrolipoyl histidinate zinc complex, a new antioxidant, attenuates hepatic ischemia-reperfusion injury in rats. J Gastroenterol Hepatol (2011) 0.81
The effect of experimental diabetes on high mobility group box 1 protein expression in endotoxin-induced acute lung injury. J Surg Res (2009) 0.80
Effect of enteral versus parenteral nutrition on inflammation and cardiac function in a rat model of endotoxin-induced sepsis. Shock (2008) 0.80
Retracted Continuous hemodiafiltration therapy ameliorates LPS-induced systemic inflammation in a rat model. J Surg Res (2010) 0.80
Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection. Antimicrob Agents Chemother (2003) 0.80
Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP. Shock (2005) 0.80
Window current through the T-type Ca2+ channel triggers the mechanism for cellular apoptosis via mitochondrial pathways. Heart Vessels (2013) 0.79
[Resistance to vecuronium bromide induced muscle relaxation in a patient with chronic renal failure and secondary hyperparathyroidism]. Masui (2007) 0.79
Monocarboxylates and glucose utilization as energy substrates in rat brain slices under selective glial poisoning--a 31P NMR study. Mol Cell Biochem (2003) 0.79